Australia markets closed

CytoDyn Inc. (CYDY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.1390+0.0034 (+2.51%)
At close: 03:54PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/05/2023
31/05/2022
31/05/2021
31/05/2020
Cash flows from operating activities
Net income
-51,690
-79,824
-210,820
-176,465
-139,936
Depreciation & amortisation
35
175
781
1,797
2,034
Deferred income taxes
0
-
-
0
0
Stock-based compensation
2,662
4,275
6,239
10,429
6,548
Change in working capital
8,059
-1,195
-4,778
-25,119
-1,593
Inventory
-
0
2,060
-79,359
-19,147
Other working capital
-12,744
-25,110
-77,723
-117,695
-68,845
Other non-cash items
-4,766
16,758
19,984
17,578
54,601
Net cash provided by operating activities
-12,744
-25,110
-77,723
-117,573
-68,804
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-122
-41
Net cash used for investing activities
0
0
0
-122
-41
Cash flows from financing activities
Debt repayment
-
-
0
-950
-2,185
Common stock issued
6,881
25,786
41,195
1,000
12,666
Dividends paid
-
-
0
-243
0
Other financing activities
-
-
-
-788
-3,236
Net cash used provided by (used for) financing activities
9,657
29,927
48,011
137,346
79,670
Net change in cash
-3,087
4,817
-29,712
19,651
10,825
Cash at beginning of period
11,110
4,231
33,943
14,292
3,467
Cash at end of period
8,023
9,048
4,231
33,943
14,292
Free cash flow
Operating cash flow
-12,744
-25,110
-77,723
-117,573
-68,804
Capital expenditure
-
-
-
-122
-41
Free cash flow
-12,744
-25,110
-77,723
-117,695
-68,845